Mir-138: A Prosurvival Oncomir For Glioma Stem Cells and Its Therapeutic Implications
Author:
- 28 February 2013
- journal article
- Published by Taylor & Francis in Future Neurology
- Vol. 8 (2) , 119-121
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS075425, F32 EB012404-01 and P41 RR023953-02)
This publication has 15 references indexed in Scilit:
- Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant GliomasCell Reports, 2012
- Pannexin2 as a novel growth regulator in C6 glioma cellsOncogene, 2009
- Lentivirus-mediated antagomir expression for specific inhibition of miRNA functionNucleic Acids Research, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- Identification of human brain tumour initiating cellsNature, 2004
- Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human GlioblastomaCancer Research, 2004
- Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activityCell, 1993
- Oncogenic activity of the c-Myc protein requires dimerization with MaxCell, 1993